Human Neurotrophin-4 (hNT-4)Product information
Product Pathways - Growth Factors/Cytokines
Human Neurotrophin-4 (hNT-4) #5592
|5592LC||50 µg (With Carrier)||---||In Stock||---|
|5592LF||50 µg (Carrier Free)||---||In Stock||---|
|5592SC||10 µg (With Carrier)||---||In Stock||---|
|5592SF||10 µg (Carrier Free)||---||In Stock||---|
Recombinant human Neurotrophin-4 (hNT-4) Gly81-Ala210 (Accession #NP_006170) was produced in E.coli at Cell Signaling Technology.
Recombinant hNT-4 does not have a Met on the amino terminus and has a calculated MW of 13,923. DTT-reduced and non-reduced protein migrate as 14 kDa polypeptides. The expected amino-terminal GVSET of recombinant hNT-4 was verified by amino acid sequencing.
>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hNT-4. All lots are greater than 98% pure.
The activity of hNT-4 was assessed by quatification of phospho-TrkB in TrkB transfected NIH/3T3 cells. The observed ED50 values are between 1-4 ng/ml.
The purity of recombinant hNT-4 was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant hNT-4 and staining overnight with Coomassie Blue.
The activity of hNT-4 was assessed. After starvation, TrkB transfected NIH/3T3 cells were treated with increasing concentrations of hNT-4 for 5 minutes. Cells were lysed, and phospho-TrkB was quatified using PathScan® Phospho-TrkB (panTyr) Sandwhich ELISA Kit #7108. OD450 is shown.
Western blot analysis of extracts from TrkB transfected NIH/3T3 cells untreated and treated with increasing concentrations of hNT-4 for 5 minutes, using Phospho-TrkA (Tyr674/675)/TrkB (Tyr706/707) (C50F3) Rabbit mAb #4621 (upper) or TrkB (80E3) Rabbit mAb #4603 (lower).
Less than 0.01 ng endotoxin/1 μg hNT-4.
With carrier: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl and 20 μg BSA per 1 μg hNT-4. Carrier free: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl.
NT-4 is a member of the structurally related neurotrophin family of proteins, which includes β-NGF, BDNF and NT-3 (1). NT-4 is expressed in a number of cell types and tissues, including neuronal cells, normal breast epithelial cells, melanocytes, activated T cells, and granulocytes (1-5). NT-4 is required for the development of peripheral sensory neurons (6,7). NT-4 may be important for the development of long term memory (8). Increased NT-4 expression in melanoma cells promotes cell proliferation and migration (5). NT-4 is secreted from cells as a precursor protein, which is proteolytically cleaved into the mature form (1). NT-4 signaling is mediated through two distinct receptors, the neurotrophin receptor p75NTR and the Trk tyrosine kinase receptor TrkB. While all neurotrophins bind to the p75NTR receptor, NT-4 preferentially binds to the TrkB receptor (1).
- Ip, N.Y. et al. (1992) Proc Natl Acad Sci U S A 89, 3060-4.
- Vanhecke, E. et al. (2011) Clin Cancer Res 17, 1741-52.
- Moalem, G. et al. (2000) J Autoimmun 15, 331-45.
- Laurenzi, M.A. et al. (1998) J Leukoc Biol 64, 228-34.
- Truzzi, F. et al. (2008) J Invest Dermatol 128, 2031-40.
- Conover, J.C. et al. (1995) Nature 375, 235-8.
- Liu, X. et al. (1995) Nature 375, 238-41.
- Xie, C.W. et al. (2000) Proc Natl Acad Sci U S A 97, 8116-21.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
PathScan is a trademark of Cell Signaling Technology, Inc.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.